Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Clinical Genitourinary Cancer|September 2, 2019
Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase InhibitorsSeung Jea Shin, Taejin Kim, Hyun Hwan Sung, et al.
Plos One|January 25, 2018
Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (≥7cm)Hakmin Lee, Chung Un Lee, Jae Ho Yoo, et al.
Urologic Oncology|November 4, 2008
Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapyHyo Song Kim, Won Seog Kim, Se Hoon Park, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2014
Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomyJun Su Park, Won Park, Hong Ryull Pyo, et al.
World Journal of Urology|October 15, 2016
Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomyHakmin Lee, Chan Kyo Kim, Byung Kwan Park, et al.
BMC Cancer|May 24, 2012
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapyJong-Mu Sun, Ji-Youn Sung, Se Hoon Park, et al.
Korean Journal of Urology|December 17, 2014
Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomyYoon Seok Suh, Hyeon Jun Jang, Wan Song, et al.
Korean Journal of Urology|March 1, 2014
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapyWan Song, U Seok Jung, Yoon Seok Suh, et al.
Urology|March 23, 2010
Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mLHong Seok Kim, Seong Soo Jeon, Jae Duck Choi, et al.
The Prostate|January 24, 2019
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivationYoung Hyo Choi, Deok Hyun Han, Seon-Woo Kim, et al.
Pageof 15